![](https://cdn.sanity.io/images/0vv8moc6/curetoday/715494bd359a38204d06e26ac0e2b4347f0e6a48-644x280.jpg?fit=crop&auto=format)
Patients Can Enroll in Pancreatic Cancer Vaccine Trial
After a phase 1 trial showed that the ELI-002 vaccine was safe and efficacious in treating stages 1 to 3 resected KRAS-mutant pancreatic cancer, researchers are now expanding their research to a phase 2 trial that is currently being conducted in cancer …